MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...

Maybe healing after an MS relapse isn't in striving to feel better, but is found in savoring where you are now, writes ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

As Thanksgiving approaches, columnist Leigh Anne Nelson is focused on what gratitude really means and appreciating the small ...

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...

The ComSLI method uses simple tools to generate detailed images of brain nerve fibers and damage in neurological diseases, ...

A wearable system that measures the brain's electrical activity can show how brain circuits are affected in people with MS, a ...

Sativex, a cannabis-based spray for MS spasticity, was bought by CNX Therapeutics. It's used as an add-on therapy in Europe ...

The MS Focus on Fashion gala celebrates both couture and ready-made adaptive styles for people with multiple sclerosis.

The FDA approved use of the Atalante X robotic exoskeleton, which allows people with mobility issues to stand upright, for MS ...

Researchers have developed a novel microscopy imaging technique to assess damaged myelin across large areas of brain tissue, ...